Profile image for Amie Hayley

Dr Amie Hayley

Rebecca L. Cooper Al & Val Rosenstrauss Fellow

Biography

Dr Amie Hayley is a Rebecca L. Cooper Al & Val Rosenstrauss Fellow at the Centre for Human Psychopharmacology at Swinburne University. Her research focuses on delineating a novel biochemical-physiological-behavioural pathways relevant to oculomotor function, visual-attentional performance and information processing capabilities under drug conditions in order to quantify the effect on neurobehaviour. She aims to identify mechanisms by which these changes translate to dangerous human behaviour, and is particularly interested in impaired driving. Her program of research is currently seeking to develop new technologies to detect and monitor driver state to reduce the impact of drug-affected driving. Dr Hayley is currently examining the appropriateness of objective eye-tracking technology to monitor and detect impairment and accident risk in stimulant affected drivers. 

Dr Hayley is the Founding Chair of the working group for Driver State Monitoring System (DSMS) through the International Council for Alcohol, Drugs and Traffic Safety (ICADTS). She also serves as the current Assistant Treasurer for the ICADTS Executive Board.

Research funding awarded in the past 3 years exceeds AUD $1MIL and she has published >35 peer reviewed publications in the field of neuropsychopharmacology, neurocognition and behavioural performance.

Research interests

Cognitive Psychology; Mood Disorders; Psychopharmacology

PhD candidate and honours supervision

Higher degrees by research

Accredited to supervise Masters & Doctoral students as Associate Supervisor.

PhD topics and outlines

Cannabidiol (CBD) treatment for insomnia: a three-week randomised controlled pilot trial (CBD-INS): The primary objective of this research is to examine whether  nightly supplementation with a novel intranasal CBD-treatment improves sleep outcomes among individuals with moderate-severe insomnia.Primary outcomes are is subjective sleep quality [sleep onset latency, sleep efficiency (%), and time awake after sleep onset) and Actigraphy outcomes.

Honours

Available to supervise honours students.

Honours topics and outlines

Amphetamine drug use and dangerous driving behaviour: Using comprehensive epidemiological survey design, this project aims to provide the first comprehensive overview of the predictors, correlates and outcomes of recreational amphetamine use on driving outcomes, and will assess whether personality factors and aggression interact to influence dangerous driving behaviour in this drug user group.

The effect of combining alcohol with wake promoting stimulants upon driving and ocular monitoring systems: : Use of Ritalin, Modafinil and Dexedrine has been linked to impulsive behaviour, disorientation and lack of co-ordination; and these effects are considerably amplified when combined with alcohol. The goal of this project is to explore the individual and combined effects of these stimulants, at therapeutic doses, with alcohol on driving performance.

Fields of Research

  • Learning, Motivation And Emotion - 520403
  • Behavioural Genetics - 520201
  • Behavioural Neuroscience - 520202
  • Cognitive Neuroscience - 520203
  • Psychopharmacology - 520205
  • Psychophysiology - 520206
  • Social And Affective Neuroscience - 520207
  • Clinical Neuropsychology - 520301
  • Cognition - 520401

Teaching areas

Neuroscience;Psychopharmacology

Awards

  • 2020, Swinburne, Vice-Chancellor’s Research Excellence Award (Early Career), Swinburne University of Technology
  • 2019, International, Young Scientist Award and Travel Stipend, International Council on Alcohol, Drugs and Traffic Safety
  • 2019, National, Australian Research Council’s (ARC) Engagement and Impact Assessment- Drugs and Driving Research Unit , Swinburne University
  • 2016, International, Young Scientist Travel Stipend, International Council on Alcohol, Drugs and Traffic Safety (ICADTS)
  • 2016, Swinburne, Deans Award for Emerging Researcher, Swinburne University
  • 2013, National, Young Scientist Travel Stipend, Institute for Breathing and Sleep (IBAS).
  • 2013, Other, Young Scientist Travel Stipend, Australasian Chronobiology Society (ACS).
  • 2013, Select, Nominee: New Investigator Award: , Australasian Sleep Association (ASA) 25th Annual Scientific Meeting
  • 2012, Other, Young Scientist Travel Stipend, Institute for Breathing and Sleep (IBAS)., Victoria University
  • 2012, Other, Young Scientist Travel Stipend, Australasian Chronobiology Society (ACS)., Victoria University

Professional memberships

  • 2017 - 2017: Committee Member, NHMRC, Australia
  • 2018 - 2018: Committee Member, NHMRC, Australia
  • 2019 - 2019: Committee Member, NHMRC, Australia
  • 2019 (current): Chair, International Council on Alcohol, Drugs and Traffic Safety (ICADTS) Special Interest Group for ‘Driver State Monitoring Systems’, International
  • 2020 - 2020: Committee Member, NHMRC, Australia
  • 2015 (current): Member, International Council on Alcohol, Drugs and Traffic Safety (ICADTS), International
  • 2015 (current): Associate, Institute for Breathing and Sleep (IBAS), Australia
  • 2019 (current): Member, Society for Critical Care Medicine (SCCM), International

Publications

Also published as: Hayley, Amie; Hayley, A.; Hayley, A. C.; Hayley, Amie C.
This publication listing is provided by Swinburne Research Bank. If you are the owner of this profile, you can update your publications using our online form.

Recent research grants awarded

  • 2021: Developing oculography as a means to determine 'fitness to drive' abstinent methamphetamine-dependent adults *; Al & Val Rosenstrauss Medical Research Fellowship
  • 2021: Driver monitoring technologies to quantify impairment for medicinal cannabis users *; Road Safety Innovation Fund
  • 2021: RFQ: Medicinal Cannabis Detectability Trial *; VicRoads
  • 2021: RFQ: Medicinal Cannabis Drug Driving Study *; Department of Health and Human Services Fund Scheme
  • 2020: Cannabidiol (CBD) treatment for insomnia: a three-week randomised controlled pilot trial with a placebo run-in period (CBD-INS) *; Cannvalate Pty Ltd
  • 2020: Modelling and full-scale pilot study of absolute zero energy houses in Melbourne *; Black T Smallfootprint
  • 2019: A randomized controlled trial investigating the effect of high CBD/low dose THC verses placebo on driving performance, sedation and mood. *; Cannvalate Pty Ltd
  • 2019: Cannabidiol (CBD) treatment for insomnia: a three-week randomised controlled pilot trial with a placebo run-in period (CBD-INS) *; Barbara Dicker Brain Science grant
  • 2019: Medicinal cannabis clinical trials *; Cannvalate Pty Ltd
  • 2018: Characterising the effect of methamphetamine and alcohol on driving behaviour and performance *; Jack Brockhoff and Edwin Flack Early Career Research Grants
  • 2018: NHMRC 2017 Standard Equipment Grant: Forum8 UC-win/Road environment modelling and scenario *; NHMRC Standard Equipment Grant
  • 2017: Characterising the effect of methamphetamine and alcohol on driving behaviour and performance *; NHMRC Early Career Fellowship
  • 2015: The effect of two concentrations of hempseed oil on oral drug detection systems and driving performance *; Department of Human Services - Contracts

* Chief Investigator